Parameterization of the GPR119 Receptor Agonist AR231453

The GPR119 receptor is a class A G protein‐coupled receptor expressed mainly in pancreatic beta cells. Since GPR119 receptor activation ameliorates Type 2 Diabetes through an increase in glucose‐dependent insulin release, the development of new GPR119 receptor agonists would be worthwhile. A better understanding of the way agonists interact with the receptor would help to design better ligands for the receptor. It also would help to better understand the agonist mechanism of action. An understanding of how agonists interact with the receptor can be acquired using molecular dynamics simulations, which cannot be performed without having force field parameters for the ligand molecule. This study presents the development of CHARMM force field parameters for AR231453, the prototypical first potent and orally available GPR119 agonist, using the Force Field Tool Kit. The parameters are validated through Normal Mode Analysis calculations and molecular dynamics simulations in combination with infrared spectroscopy. © 2017 Wiley Periodicals, Inc.

[1]  Didier Bagnol,et al.  A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. , 2007, Endocrinology.

[2]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[3]  William Thomsen,et al.  Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. , 2008, Journal of medicinal chemistry.

[4]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[5]  J. Holst,et al.  GPR119 as a fat sensor. , 2012, Trends in pharmacological sciences.

[6]  Sang-Uk Kang,et al.  GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119. , 2013, Drug discovery today.

[7]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[8]  Jing Zhang,et al.  Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences , 2013 .

[9]  Alexander D. MacKerell,et al.  Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing , 2012, J. Chem. Inf. Model..

[10]  C. Reynet,et al.  GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity , 2008, British journal of pharmacology.

[11]  Alexander D. MacKerell,et al.  Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges , 2012, J. Chem. Inf. Model..

[12]  Klaus Schulten,et al.  Rapid parameterization of small molecules using the force field toolkit , 2013, J. Comput. Chem..

[13]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[14]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[15]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..